Gain Therapeutics Inc. (GANX)
NASDAQ: GANX
· Real-Time Price · USD
1.73
0.19 (12.34%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:49 PM EDT
Gain Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 82.24K | 82.24K | 82.24K | 64.8K | 64.8K | 64.8K | 119.98K | 195.29K | 195.29K | 290.39K | 280.22K | 176.45K | 203.79K | 197.87K | 158.13K | 130.93K | 110.28K | 27.48K |
Cost of Revenue | 63.61K | 84.2K | 84.07K | 86.35K | 85.22K | 64.63K | 44.1K | 38.62K | 18.11K | 36.35K | 44.56K | 26.45K | 26.45K | 8.21K | n/a | 975.61K | 1.4M | 1.84M |
Gross Profit | -63.61K | -84.2K | -84.07K | -86.35K | -85.22K | -84.86K | -64.34K | 81.25K | 82.15K | 179.25K | 216.05K | -1.34M | -3.77M | -5.55M | -7.01M | -6.54M | -4.51M | -3.24M |
Operating Income | -17.25M | -20.34M | -20.35M | -21.43M | -21.85M | -21.4M | -22.25M | -22.41M | -22.27M | -19.72M | -17.78M | -16.42M | -16.31M | -14.65M | -13.83M | -12.23M | -8.42M | -5.43M |
Interest Income | 240.24K | 282.21K | 357.1K | 411.51K | 412.1K | 457.5K | 342.2K | 235.93K | 129.93K | 59.9K | 59.9K | 59.9K | 59.9K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -17.84M | -20.31M | -19.87M | -21.32M | -21.54M | -21.06M | -22.19M | -22.08M | -21.93M | -19.35M | -17.5M | -16.13M | -16.23M | -14.71M | -13.89M | -12.32M | -8.45M | -5.44M |
Net Income | -18.59M | -20.93M | -20.41M | -21.37M | -21.6M | -21.14M | -22.27M | -22.22M | -22.06M | -19.46M | -17.59M | -16.14M | -16.24M | -14.71M | -13.89M | -12.33M | -8.46M | -5.44M |
Selling & General & Admin | 8.39M | 9.8M | 9.55M | 9.46M | 10.14M | 10.14M | 10.77M | 11.04M | 11.31M | 10.26M | 9.54M | 9.03M | 8.43M | 7.55M | 6.83M | 5.7M | 3.91M | 2.2M |
Research & Development | 8.85M | 10.53M | 10.77M | 11.92M | 11.67M | 11.22M | 11.51M | 11.42M | 11.02M | 9.61M | 8.38M | 7.58M | 8.09M | 7.3M | 7.16M | 6.67M | 4.62M | 3.26M |
Other Expenses | -11.31K | -11.31K | -11.31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.93K | 7.56K | n/a | n/a | -18.93K | -14.25K | -13.07K |
Operating Expenses | 17.23M | 20.32M | 20.31M | 21.38M | 21.81M | 21.36M | 22.28M | 22.46M | 22.33M | 19.87M | 17.92M | 16.6M | 16.51M | 14.85M | 13.98M | 12.36M | 8.09M | 4.58M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.65K | 1.65K | 1.65K | 1.65K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -12.53K | -27.29K | -27.29K | -27.29K | -14.77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.25M | 20.34M | 20.35M | 21.43M | 21.85M | 21.4M | 22.31M | 22.46M | 22.33M | 19.87M | 17.92M | 16.6M | 16.51M | 14.85M | 13.98M | 12.36M | 8.53M | 5.46M |
Income Tax Expense | 757.45K | 617.45K | 536.82K | 46.58K | 57.04K | 82.42K | 79.28K | 142.88K | 125.47K | 108.03K | 92.98K | 6.63K | 7.69K | 2.21K | 4.01K | 10.88K | 6.66K | 7.52K |
Shares Outstanding (Basic) | 30.34M | 28.69M | 27.13M | 26.53M | 19.22M | 17.98M | 16.21M | 12.7M | 12.39M | 11.94M | 11.88M | 11.88M | 11.83M | 11.88M | 10.17M | 11.88M | 11.88M | 11.6M |
Shares Outstanding (Diluted) | 30.34M | 28.69M | 27.13M | 26.53M | 19.22M | 17.98M | 16.21M | 12.7M | 12.39M | 11.94M | 11.88M | 11.88M | 11.88M | 11.88M | 10.17M | 11.88M | 11.88M | 11.6M |
EPS (Basic) | -0.66 | -0.89 | -0.95 | -1.1 | -1.3 | -1.5 | -1.71 | -1.81 | -1.82 | -1.63 | -1.48 | -1.41 | -1.42 | -1.29 | -1.22 | -1.05 | -0.74 | -0.49 |
EPS (Diluted) | -0.66 | -0.89 | -0.95 | -1.1 | -1.3 | -1.5 | -1.71 | -1.81 | -1.82 | -1.63 | -1.48 | -1.41 | -1.42 | -1.29 | -1.22 | -1.05 | -0.74 | -0.49 |
EBITDA | -17.21M | -20.28M | -20.28M | -21.37M | -21.81M | -21.37M | -22.21M | -22.36M | -22.23M | -19.68M | -17.75M | -16.42M | -16.28M | -14.61M | -13.79M | -12.19M | -8.41M | -5.42M |
EBIT | -17.83M | -20.34M | -20.35M | -21.43M | -21.85M | -21.4M | -22.25M | -22.41M | -22.27M | -19.72M | -17.78M | -16.42M | -16.31M | -14.65M | -13.83M | -12.23M | -8.42M | -5.43M |
Depreciation & Amortization | 63.61K | 84.2K | 84.07K | 86.35K | 85.22K | 84.86K | 83.58K | 78.1K | 77.2K | 75.2K | 64.17K | 51.85K | 86.51K | 70.42K | 65.61K | 62.66K | 10.78K | 10.89K |